12:00 AM
Jan 14, 2013
 |  BC Week In Review  |  Company News  |  Other News

X-Chem, X-Rx pharmaceuticals news

Newco X-Rx spun out of X-Chem. Rick Wagner, who is CEO of X-Rx, said the company will develop small molecule therapies against undisclosed "intractable"...

Read the full 100 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >